Tag: Drug Discovery
New way to track particles in soft colloids using optical tweezers...
Laponite is a widely used raw material in the pharmaceutical and cosmetics industries
FACE TO FACE: Dr Kanury V S Rao, Co-Founder & CSO,...
In a highly informative conversation, Dr Kanury V S Rao, Co-Founder & Chief Scientific Officer, PredOmix spoke to Rahul Koul, Chief Editor, BioVoice News...
PhoreMost and ThinkCyte collaborate to advance AI based drug discovery
PhoreMost’s SITESEEKER platform, based on the Company’s core proprietary ‘Protein Interference’ (PROTEINi) technology, probes the entire proteome to systematically unmask new and unanticipated druggable sites
Clinical diagnostics & drug discovery to account for bulk of lab...
According to a latest report, the market is poised to experience significant gains, posting a CAGR exceeding 7% through 2031.....................
Aragen expands discovery research agreement with Boehringer Ingelheim
The partnership also allows for the integrated up-scaling of compounds for larger pre-clinical studies.......................
CDRI invites Indian scientists to apply for its ‘Excellence in Drug...
There are two separate individual awards each in the area of Chemical and Life Sciences. Each award carries a cash prize of Rs 20,000/- and a citation...............
Role of supercomputers in boosting drug discovery
In this contributory column, Deepak Jha, Deputy General Manager- AIPF, NEC Technologies explains how faster computational power plays an integral role in expediting the overall drug discovery process and bringing down the effort from years to months..............
6 bio-scientists awarded Swarna Jayanti Fellowships for 2018-19
The Swarna Jayanti Fellowships scheme was instituted by Government of India to commemorate India's fiftieth year of independence................
CSIR-CDRI organizes a skill development program for secondary metabolites analysis
The objective of the program was to train the participants for secondary metabolites analysis using LC-MS and HRMS instruments. Secondary metabolites are considered as main key for drug discovery and development................
“IMTECH’s translational science agenda holds a big promise”
Read the exclusive freewheeling interview with Dr Anil Koul, Director, CSIR-Institute of Microbial Technology-Chandigarh, where he shares his long term vision for the premier institute besides his insights on the required ingredients for the Indian innovation system. A Must Read......................